Teratogenic effects of retinoic acid are modulated in mice lacking expression of epidermal growth factor and

Barbara D Abbott1, Deborah S Best, Michael G Narotsky

  • 1Reproductive Toxicology Division, National Health and Environmental Effects Research Laboratory, Office of Research and Development, U.S. Environmental Protection Agency, 2525 East Highway 54, Durham, NC 27713, USA. Abbott.barbara@epa.gov

Abstract

Insights

This study reveals that knockout mice lacking epidermal growth factor (EGF) or transforming growth factor-alpha (TGFalpha) show altered susceptibility to retinoic acid (RA)-induced birth defects, highlighting their crucial roles in embryonic development and teratogenic responses.

Area of Science:

  • Developmental Biology
  • Teratology
  • Genetics

Background:

  • Epidermal growth factor (EGF) and transforming growth factor-alpha (TGFalpha) are critical regulators of embryonic cell proliferation and differentiation.
  • Retinoic acid (RA) is a known teratogen that can induce birth defects, including cleft palate (CP).
  • Previous studies suggest a link between RA-induced CP and altered expression of TGFalpha, EGF, and their receptor.

Purpose of the Study:

  • To investigate the specific roles of EGF and TGFalpha in mediating the teratogenic effects of RA during embryonic development.
  • To determine how the absence of EGF or TGFalpha influences the incidence and severity of RA-induced skeletal and visceral malformations.

Main Methods:

  • Wild-type (WT), EGF knockout (KO), and TGFalpha KO mice were exposed to a single oral dose of RA or a control vehicle on specific days of gestation (GD 10-12).
  • Fetal outcomes were assessed on GD 18 for external, visceral, and skeletal abnormalities.
  • Genetic background of mice included mixed background and C57BL/6J.

Main Results:

  • RA exposure induced skeletal and visceral defects across all genotypes.
  • EGF KO mice exhibited a reduced incidence of RA-induced cleft palate when exposed on GD 12 compared to WT.
  • TGFalpha KO mice showed an increased incidence of CP with RA exposure on GD 10 and increased limb/digit defects.
  • Both EGF and TGFalpha KO mice displayed altered incidences of skeletal defects (limbs, vertebrae, sternebrae, ribs) and renal pelvis dilation, with varying amelioration or exacerbation of RA's effects.

Conclusions:

  • EGF and TGFalpha play significant, genotype-dependent roles in modulating the teratogenic effects of RA.
  • The findings support the involvement of EGF and TGFalpha signaling pathways in the embryonic response to RA exposure.
  • Targeting these pathways could offer insights into preventing or mitigating RA-induced developmental abnormalities.

Related Concept Videos